title: [Prognostic value of Jass classification of rectal cancer compared to original Dukes system].
abstract: The aim of this study was to assess the prognostic value of Jass and Dukes classification of rectal cancer.
  
  
  METHODS
  The impact of these staging systems on five-year disease-free survival has been estimated in univariate and multivariate analysis for the group of ninety-two curatively treated patients.
  
  
  RESULTS
  In univariate analysis a relationship between survival and stage of disease has been found with a high degree of statistical significance for both Jass (I: 89.3 +/- 5.9; II: 54.2 +/- 10.2, p< 0.005; III: 14.3 +/- 9.4, p< 0.001; IV: 12.0 +/- 6.5, p < 0.001) and Dukes (A: 88.1 +/- 6.4; B: 41.0 +/- .9, p < 0.001; C: 15.4 +/- 7.1, p < 0.001) classifications. Cox regression model has identified Jass system as the best predictor of prognosis (II: p < 0.05; III: p < 0.001; IV: p < 0.001) and has shown the lack of significance for Dukes classification. In multivariate analysis of specific pathological features constituting Jass scale a significant and independent influence on survival (p < 0.05) has been noticed for the depth of penetration through the bowel wall, type of tumour growth and lymphocytic infiltration but not for the number of positive lymph nodes.
  
  
  CONCLUSIONS
  Jass classification of rectal cancer is a prognostically effective modification of Dukes system as the result of addition of histological parameters significantly affects the prognosis.
authors.affiliation: Z II Oddziału Chirurgii Onkologicznej Dolnoślaskiego Centrum Onkologii we Wrocławiu. chir2@chir2.am.wroc.pl
authors.forename: Bartłomiej
authors.initials: B
authors.lastname: Szynglarewicz
authors.forename: Zygmunt
authors.initials: Z
authors.lastname: Grzebieniak
authors.forename: Józef
authors.initials: J
authors.lastname: Forgacz
authors.forename: Marek
authors.initials: M
authors.lastname: Pudełko
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Rapała
mesh_terms: D000230:Adenocarcinoma / Q000145:classification* / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D011044:Poland; D011379:Prognosis; D012004:Rectal Neoplasms / Q000145:classification* / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D012044:Regression Analysis; D016019:Survival Analysis